Article information
Full text is only aviable in PDF
Bibliografía
[1.]
D.A. Holaday, A.M. Langer, W. Nicholson, A. Rohl.
Historical background.
Asbestos and disease,
[2.]
W.E. Cooke.
Pulmonary asbestosis Br Med J, 2 (1927), pp. 1024
[4.]
J.C. Wagner, C.A. Sleggs, P. Marchand.
Diffusse pleural mesothelioma and asbestos exposure in the North Western cape Province.
Br J Ind Med, 17 (1960), pp. 260
[5.]
M. Greenberg.
Biological effects of asbestos: New York Academy of Sciences 1964.
Am J Ind Med, 43 (2003), pp. 543-552
[6.]
M. Greenberg.
Cape asbestos, barking, health and enviroment: 1928- 1946.
Am J Ind Med, 43 (2003), pp. 109-119
[7.]
T. Kauppinen, J. Toikkanen, D. Pedersen, R. Young, W. Ahrens, P. Boffetta, et al.
Occupational exposure to carcinogens in the European Union.
Occup Environ Med, 57 (2000), pp. 10-18
[8.]
J. Leigh, P. Davidson, L. Hendrie, D. Berry.
Malignat mesothelioma in Australia, 1945-2000.
Am J Ind Med, 41 (2002), pp. 188-201
[9.]
J. Peto, J.T. Hodgson, F.E. Matthews, et al.
Continuing increase in mesothelioma mortality in Britain.
Lancet, 345 (1995), pp. 535-539
[10.]
S. Mattioli, D. Nini, G. Manzini, F.S. Violante.
Past asbestos exposure levels in foundries and cement-asbestos factories.
Am J Med, 34 (1998),
[11.]
M. Erdinc, E. Endrinc, G. Cok, M. Polatli.
Respiratory impairment due to asbestos exposure in brake-lining workers.
Environ Res, 91 (2003), pp. 151-153
[12.]
W.N. Rom, S.R. Amar, S. Hoffman.
Malignant masothelioma from neigborhood exposure to anthophyllite asbestos.
Am J Ind Med, 40 (2001), pp. 211-214
[14.]
A. Churg.
Deposition and clearance of chrysotile asbestos.
Ann Occup Hyg, 38 (1994), pp. 625-633
[16.]
Y. Suzuki, N. Kohyama.
Traslocation of inhaled asbestos fibers from the lung to others tissues Am J Ind Med, 19 (1992), pp. 701-704
[17.]
P. Sebastien, X. Janson, A. Gaudichet.
Asbestos retention in human respiratory tissues: comparative measurements in lung parenchyma and in parietal pleura.
Biological effects of mineral fibres, pp. 237-246
[18.]
R. Begin, J.W. Christman.
Detailed occupational history: the cornerstone in the diagnosis of asbestos-related lung disease.
Am J Respir Crit Care Med, 163 (2001), pp. 705-710
[19.]
A. Churg, M.L. Warnock.
Analysis of the cores of ferruginous asbestos bodies from the general population. II. True asbestos bodies and pseudoasbestos bodies.
Lab Invest, 40 (1979), pp. 31-38
[20.]
A. Churg, M.L. Warnock.
Analysis of the cores of ferruginous asbestos bodies from the general population. III. Patients with environmental exposure.
Lab Invest, 40 (1979), pp. 622-626
[21.]
A. Churg.
Fiber counting and analysis of the diagnosis of asbestos related disease.
Hum Pathol, 14 (1982), pp. 381-392
[22.]
I.J. Selikoff, W.J. Nicholson, A.M. Langer.
Asbestos air pollution.
Arch Environ Health, 25 (1972), pp. 1-4
[23.]
V.L. Roggli, S.D. Greenberg, J.L. McLarty, G.A. Hurts, L.R. Hieger, M.L. Farley, et al.
Comparison of sputum and lung asbestos body counts in former asbestos workers.
Am Rev Respir Dis, 122 (1980), pp. 941-945
[24.]
R. Pifarré, E. Monsó, A. Rosell, M. Llatjós, I. Badorrey, J. Morera.
Identificación de cuerpos de asbesto en el lavado broncoalveolar.
Arch Bronconeumol, 35 (1999), pp. 113-116
[25.]
P. De Vuyst, P. Dumortier, E. Moulin, N. Yourassowsky, P. Roomans, P. De Francquen, et al.
Asbestos bodies in bronchoalveolar lavage reflect lung asbestos body concentration.
Eur Respir J, 1 (1988), pp. 362-367
[26.]
P. Sebastien, B. Armstrong, G. Monchaux, J. Bignon.
Asbestos bodies in bronchoalveolar lavage fluid in lung parenchyma.
Am Rev Respir Dis, 137 (1988), pp. 75-78
[27.]
P. De Vuyst, J. Jedwab, P. Dumortier, G. Vandermoten, R. Vande Weyer, J.C. Yernault.
Asbestos bodies in bronchoalveolar lavage.
Am Rev Respir Dis, 126 (1982), pp. 972-976
[28.]
J. Bignon, P. Sebastien, A. Gaudichet, M. Bientz.
Analysis of mineral particles recovered by bronchoalveolar lavage for diagnosis of dust-related lung diseases.
Am Rev Respir Dis, 117 (1978), pp. A218
[29.]
A. Karjalainen, R. Piipari, T. Mäntylä, M. Mönkkönen, M. Nurminen, P. Tukiainen, et al.
Asbestos bodies in bronchoalveolar lavage in relation to asbestos bodies and asbestos fibres in lung parenchyma.
Eur Respir J, 9 (1996), pp. 1000-1005
[30.]
F.D. Pooley, D.L. Ranson.
Comparison of the results of asbestos fibre dust counts in lung tissue obtained by analytical electron microscopy and light microscopy.
J Clin Pathol, 39 (1986), pp. 313-317
[31.]
P. De Vuyst, A. Karjalainen, P. Dumortier, J.C. Pairon, E. Monsó, P. Brochard, et al.
Guidelines for mineral fibre analysis in biological samples: report of the ERS Working Group.
Eur Respir J, 11 (1998), pp. 1416-1426
[32.]
R.F. Dodson, D. Greenberg, M.G. Williams, C.J. Corn, M.F. O'Sullivan, G.A. Hurst.
Asbestos content in lungs of occupationally and nonoccupationally exposed individuals.
Jama, 252 (1984), pp. 68-71
[33.]
A. Churg, M.L. Warnock.
Correlation of quantitative asbestos body counts and occupation in urban patients.
Arch Pathol Lab Med, 101 (1977), pp. 629-634
[34.]
B.W. Case, P. Sebastien, C.J. McDonald.
Lung fiber analysis in accident victims: a biological assessment of general environment exposures.
Arch Environ Health, 43 (1988), pp. 178-179
[35.]
E. Monsó, A. Texidó, D. López, X. Aguilar, J. Fiz, J. Ruiz, et al.
Asbestos bodies in normal lung of Western Mediterranean populations with no occupational exposure to inorganic dust.
Ach Environ Health, 50 (1995), pp. 305-311
[36.]
F.D. Pooley.
Asbestos bodies: their formation, composition and character.
Environ Res, 5 (1972), pp. 363-379
[37.]
E. Monsó, J.M. Tura, J. Pujadas, F. Morell, J. Ruiz, J. Morera.
Lung dust content in idiopatic pulmonary fibrosis: a study with scanning electron microscopy and energy dispersive X ray analysis.
Br J Ind Med, 48 (1991), pp. 327-331
[38.]
E. Moulin, N. Yourassowsky, P. Dumortier, P. De Vuyst, J.C. Yernault.
Electron microscopic analysis of asbestos body cores from the Belgian urban population.
Eur Respir J, 1 (1988), pp. 818-822
[39.]
V.L. Kinnula.
Oxidant and antioxidant mechanism of lung disease caused by asbestos fibres.
Eur Respir J, 14 (1999), pp. 706-716
[40.]
W. Rom, W.D. Travis, A.R. Brody.
Cellular and molecular basis of the asbestos related diseases.
Am Rev Respir Dis, 143 (1991), pp. 408-422
[41.]
G. Hillerdal.
Asbestos-related pleural disease including diffuse malignant mesothelioma.
Eur Respir Mon, 22 (2002), pp. 189-203
[42.]
G. Hillerdal.
Pleural plaques and risk for bronchial carcinoma and mesothelioma. A prospective study.
Chest, 105 (1994), pp. 144-150
[43.]
J. Van Cleemput, H. De Raeve, J.A. Verschakelen, J. Rombouts, L.M. Lacquet, B. Nemery.
Surface of localized pleural plaques quantitated by computed tomography scanning: no relation with cumulative asbestos exposure and no effect on lung function.
Am J Respir Crit Care Med, 163 (2001), pp. 598-599
[44.]
A. Karjalainen, P.J. Karhunen, K. Lalv.
Pleural plaques and exposure to mineral fibres in a male urban necropsy population.
Occup Environ Med, 51 (1994), pp. 456-460
[45.]
J. Van Cleemput, H. De Raeve, J.A. Verschakelen, J. Rombouts, L.M. Lacquet, B. Nemery.
Surface of localized pleural plaques quantitated by computed tomography scanning: no relation with cumulative asbestos exposure and no effect on lung function.
Am J Respir Crit Care, 163 (2001), pp. 598-599
[46.]
M. Stephens, A.R. Gibbs, F.D. Pooley, J.C. Wagner.
Asbestos induced diffuse pleural fibrosis: pathology and mineralogy.
Thorax, 42 (1987), pp. 583-588
[47.]
International Labour Office.
Guidelines for the use of International Classification Radiographs of Pneumoconioses.
Revised edition 1980,
[48.]
G. Hillerdal.
Pleural lesions and the ILO classificacion: the need of a revision.
Am J Ind Med, 19 (1991), pp. 125-130
[49.]
M. Tiitola, L. Kivisaari, A. Zitting, M.S. Huuskonen, S. Kaleva, A. Tossavainen, et al.
Computed tomography of asbestos-related pleural abnormalities.
Arch Occup Environ Health, 75 (2002), pp. 224-228
[50.]
J. Bourbeau, P. Ernst, J. Chrome, et al.
The relationship between respiratory impairment and asbestos related pleural abnormality in an active work force.
Am Rev Respir Dis, 142 (1999), pp. 837
[51.]
R.F. Sison, R.H. Hruban, W.G. Moore, J.E. Kulman, P.S. Wheller, G.M. Hutchins.
Pulmonary diseases associated with pleural “asbestos” plaques.
Chest, 95 (1989), pp. 831-835
[53.]
G.R. Epler, T.C. McLoud, E.A. Gaensler.
Prevalence and incidence of benign asbestos pleural effusion in a working population.
Jama, 247 (1982), pp. 617
[54.]
M. Metintas, I. Ucgun, O. Elbek, S. Erginel, S.A. Metintas, M. Kolsuz, et al.
Computed tomography features in malignant mesothelioma and other commonly seen pleural diseases.
Eur J Radiol, 41 (2002), pp. 1-9
[55.]
D.A. Schwartz.
New developments in asbestos induced pleural disease.
Chest, 99 (1991), pp. 191-198
[57.]
American Thoracic Society.
The diagnosis of non-malignant diseases related to asbestos.
Am Rev Respir Dis, 134 (1986), pp. 363-368
[58.]
R. Begin, A. Cantin, S. Mase.
Recent advances in the clinical assessment and pathogenesis of the mineral dust pneumoconioses.
Eur Respir J, 2 (1989), pp. 988-1001
[59.]
B.T. Mossman, A. Churg.
Mechanisms in the pathogenesis of asbestosis and silicosis Am J Respir Crit Care Med, 157 (1998), pp. 1666-1680
[60.]
J.E. Craighead, J.L. Abraham, A. Churg, et al.
The pathology of asbestos associated diseases of the lung and pleural cavities: diagnostic criteria and proposed grading scheme.
Arch Pathol Lab Invest, 106 (1982), pp. 544-595
[61.]
R. Bégin, G. Ostiguy, R. Filion, et al.
Computed tomography in the early detection of asbestosis.
Br J Ind Med, 50 (1993), pp. 689-698
[62.]
M. Akira.
Hihg-resolution CT in the evaluation of occupational and environmental disease.
Radiol Clin North Am, 40 (2002), pp. 43-59
[63.]
W. Morgan, J.B. Gee.
Asbestos-related diseases.
Occupational lung diseases, 3rd ed, pp. 318-325
[64.]
R. Begin.
Asbestos related diseases.
Eur Respir Mon, 11 (1999), pp. 1158-1177
[65.]
W. Weiss.
Asbestosis: a marker for increased risk of lung cancer among workers exposed to asbestos.
Chest, 115 (1999), pp. 536-549
[66.]
International Agency for Research on Cancer.
Overall evaluations of carcinogenyty: an Updating of IARC Monographs Volumes,
[67.]
R. Begin, J.J. Gauthier, M. Desmeules, G. Ostiguy.
Work related mesothelioma in Quebec 1967-1990.
Am J Ind Med, 22 (1992), pp. 531-542
[68.]
D.H. Yates, B. Corrin, P.N. Stildolph, et al.
Malignant mesothelioma in South East England: clinicopatological experience of 272 cases.
Thorax, 45 (1997), pp. 124-135
[69.]
A. Agudo, C. González, M.J. Bleda, J. Ramírez, S. Hernández, F. López, et al.
Occupation and risk of malignant pleural mesothelioma: a case-control study in Spain.
Am J Ind Med, 37 (2000), pp. 159-168
[70.]
C. Magnani, A. Agudo, C.A. González, A. Andrion, A. Calleja, E. Chellini, et al.
Multicentric study of non malignant pleural mesothelioma and non-occupational exposure to asbestos.
Brit J Cancer, 83 (2000), pp. 104-111
[71.]
World Health Organization.
Crisotyle asbestos.
Environmental Health Criteria 203, pp. 144
[72.]
G. Hillerdal.
Malignant mesothelioma 1982: review of 4710 published cases.
Br J Dis Chest, 77 (1983), pp. 321-343
[73.]
T. Van Gelder, R.A. Damhuis, H.C. Hoogstedon.
Prognostic factors and survival in malignant pleural mesothelioma.
Eur Respir J, 7 (1994), pp. 1035-1038
[74.]
C.R. McGavin, P.D. Hughes.
Finger clubbing in malignat mesothelioma and benign asbestos pleural disease.
Respir Med, 92 (1998), pp. 691-692
[75.]
N.G. Ordóñez.
Value of Ber-EP4 antibody in differentiating epithelial pleural mesothelioma from adenocarcinoma. The M.D. Anderson experience and a critical review of the literature.
Am J Clin Pathol, 109 (1998), pp. 85-89
[76.]
International Mesothelioma Interest Group.
A proposed new international TNM staging system for malignat mesothelioma.
Chest, 108 (1995), pp. 1122-1128
[77.]
S.M. Albelda.
Advances in the treatment of malignant pleural mesothelioma.
Chest, 116 (1999), pp. 504-520
[78.]
D.H. Sterman, L. Kaiser, S.M. Albelda.
Advances in the treatment of malignant pleural mesothelioma Chest, 116 (1999), pp. 504-520
[79.]
S.M. Albelda.
Gene therapy for lung cancer and mesothelioma.
Chest, 111 (1997), pp. 144S-149S
[80.]
W.R. Smythe.
Current therapy for malignant mesothelioma.
Curr Oncol Rep, 4 (2002), pp. 305-313
[81.]
K.M. Lynch, W.A. Smith.
Pulmonary asbestosis. Carcinoma of lung in asbesto- silicosis.
Am J Cancer, 24 (1935), pp. 56
[82.]
L. Simonato, P. Vineis, A.C. Fletcher.
Estimates of the proportion of lung cancer attributable to occupational exposure.
Carcinogenesis, 9 (1988), pp. 1159-1165
[83.]
F. Mollo, C. Magnani, P. Bo, P. Burlo, M. Cravello.
The attribution of lung cancers to asbestos exposure.
Am J Clin Pathol, 117 (2002), pp. 90-95
[84.]
M.I. Badorrey, E. Monso, A. Teixido, R. Pifarré, A. Rosell, M. Llatjos.
Frecuencia y riesgo de neoplasia broncopulmonar relacionada con asbestos.
Med Clin (Barc), 117 (2001), pp. 1-6
[85.]
B. Lee, J.C. Wain, K.T. Kelsey, J.K. Wiencke, D.C. Christiani.
Association of cigarette smoking and asbestos exposure with location and histology of lung cancer.
Am J Respir Crit Care Med, 157 (1998), pp. 748-755
[86.]
M.B. Schabath, M.R. Spitz, G.L. Delclos, G.B. Gunn, L.W. Whitehead, X. Wu.
Association between asbestos exposure, cigarette smoking, myeloperoxidase (MPO) genotypes and lung cancer risk.
Am J Ind Med, 42 (2002), pp. 29-37
[87.]
M. Tiitola, L. Kivisaari, M.S. Huuskonen, K. Mattson, H. Koskinen, H. Lehtola, et al.
Computed tomography for lung cancer in asbestos-exposed workers.
Lung Cancer, 163 (2002), pp. 705-710
[88.]
Fundación Laboral de la Construcción del Principado de Asturias.
Amianto y salud,
[89.]
D. Berrigan.
Respiratory cancer and exposure to man-made vitreous fibers: a systematic review.
Am J Ind med, 42 (2002), pp. 354-362
Copyright © 2004. Sociedad Española de Neumología y Cirugía Torácica
